NCT05801029
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05801029
Title A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations (OSTARA)
Acronym OSTARA
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Research Site Hong Kong 150001 Hong Kong Details
Research Site Hong Kong HKG Hong Kong Details
Research Site Hong Kong Hong Kong Details
Research Site Shatin 00000 Hong Kong Details
Research Site George Town 10990 Malaysia Details
Research Site Kota Bharu 15586 Malaysia Details
Research Site Kuala Lumpur 50586 Malaysia Details
Research Site Kuala Lumpur 59100 Malaysia Details
Research Site Kuantan 25100 Malaysia Details
Research Site Kuching 93200 Malaysia Details
Research Site Singapore 169610 Singapore Details
Research Site Singapore 308433 Singapore Details
Research Site Anyang-si 14068 South Korea Details
Research Site Busan 49241 South Korea Details
Research Site Daegu 42415 South Korea Details
Research Site Seoul 08308 South Korea Details
Research Site Seoul 5030 South Korea Details
Research Site Kaohsiung City 82445 Taiwan Details
Research Site Taichung 404 Taiwan Details
Research Site Taichung 40705 Taiwan Details
Research Site Tainan 73657 Taiwan Details
Research Site Taipei 10048 Taiwan Details
Research Site Taipei 110 Taiwan Details
Research Site Yunlin 640 Taiwan Details
Research Site Bangkok 10330 Thailand Details
Research Site Bangkok 10400 Thailand Details
Research Site Bangkok 10700 Thailand Details
Research Site Chiang Mai 50200 Thailand Details
Research Site Songkhla 90110 Thailand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field